No Data
No Data
Ligand Pharmaceuticals Down Nearly 9%, on Pace for Largest Percent Decrease Since January 2023 -- Data Talk
Ligand Pharmaceuticals Incorporated ( LGND ) is currently at $80.10, down $7.81 or 8.88% --Would be lowest close since May 7, 2024, when it closed at $73.22 --On pace for largest percent decrease si
Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating
Craig-Hallum analyst Matt Hewitt maintains $Ligand Pharmaceuticals(LGND.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 43.9% and a total average return of -3.8% o
Ligand to Participate in Upcoming Investor Conferences
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that Todd Davis (Chief Executive Officer) and Tavo Espinoza (Chief Financial Officer) will participate in the following upcoming investor
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Taking a wider view, although not as strong as the last mon
Ligand Pharmaceuticals(LGND.US) Director Sells US$77,713.38 in Common Stock
$Ligand Pharmaceuticals(LGND.US)$ Director Gray Nancy Ryan sold 934 shares of common stock on May 9, 2024 at an average price of $83.2049 for a total value of $77,713.38.Source: Announcement What is s
Ligand Pharmaceuticals(LGND.US) Officer Sells US$1.15 Million in Common Stock
$Ligand Pharmaceuticals(LGND.US)$ Officer Espinoza Octavio sold 13,293 shares of common stock on May 15, 16, 17, 2024 at an average price of $86.2637 for a total value of $1.15 million.Source: Announc